SKIN Valuation

Beauty Health Co

Add to Watchlist

Advanced Chart

2.380

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

SKIN Relative Valuation

SKIN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SKIN is overvalued; if below, it's undervalued.

Trade Smarter with Intellectia.AI

300K+ trust us for AI trading signals that capture market momentum early!

Trade Smarter with Intellectia.AI

300K+ trust us for AI trading signals that capture market momentum early!

Historical Valuation

Beauty Health Co (SKIN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.95 is considered Undervalued compared with the five-year average of 51.45. The fair price of Beauty Health Co (SKIN) is between 2.77 to 17.52 according to relative valuation methord. Compared to the current price of 2.38 USD , Beauty Health Co is Undervalued By 14.19%.

Relative Value

Fair Zone

2.77-17.52

Current Price：2.38

14.19%

Undervalued

464.00

Trailing

Forward

15.77

EV/EBITDA

Beauty Health Co. (SKIN) has a current EV/EBITDA of 15.77. The 5-year average EV/EBITDA is 38.25. The thresholds are as follows: Strongly Undervalued below -53.33, Undervalued between -53.33 and -7.54, Fairly Valued between 84.05 and -7.54, Overvalued between 84.05 and 129.84, and Strongly Overvalued above 129.84. The current Forward EV/EBITDA of 15.77 falls within the Historic Trend Line -Fairly Valued range.

-21.24

EV/EBIT

Beauty Health Co. (SKIN) has a current EV/EBIT of -21.24. The 5-year average EV/EBIT is 91.95. The thresholds are as follows: Strongly Undervalued below -538.19, Undervalued between -538.19 and -223.12, Fairly Valued between 407.02 and -223.12, Overvalued between 407.02 and 722.10, and Strongly Overvalued above 722.10. The current Forward EV/EBIT of -21.24 falls within the Historic Trend Line -Fairly Valued range.

0.95

Beauty Health Co. (SKIN) has a current PS of 0.95. The 5-year average PS is 3.70. The thresholds are as follows: Strongly Undervalued below -3.64, Undervalued between -3.64 and 0.03, Fairly Valued between 7.37 and 0.03, Overvalued between 7.37 and 11.05, and Strongly Overvalued above 11.05. The current Forward PS of 0.95 falls within the Historic Trend Line -Fairly Valued range.

-93.43

P/OCF

Beauty Health Co. (SKIN) has a current P/OCF of -93.43. The 5-year average P/OCF is 34.53. The thresholds are as follows: Strongly Undervalued below -92.39, Undervalued between -92.39 and -28.93, Fairly Valued between 97.99 and -28.93, Overvalued between 97.99 and 161.44, and Strongly Overvalued above 161.44. The current Forward P/OCF of -93.43 falls within the Strongly Undervalued range.

13.43

P/FCF

Beauty Health Co. (SKIN) has a current P/FCF of 13.43. The 5-year average P/FCF is -277.95. The thresholds are as follows: Strongly Undervalued below -2599.42, Undervalued between -2599.42 and -1438.68, Fairly Valued between 882.78 and -1438.68, Overvalued between 882.78 and 2043.52, and Strongly Overvalued above 2043.52. The current Forward P/FCF of 13.43 falls within the Historic Trend Line -Fairly Valued range.

Beauty Health Co (SKIN) has a current Price-to-Book (P/B) ratio of 3.97. Compared to its 3-year average P/B ratio of 5.49 , the current P/B ratio is approximately -27.64% higher. Relative to its 5-year average P/B ratio of 12.33, the current P/B ratio is about -67.77% higher. Beauty Health Co (SKIN) has a Forward Free Cash Flow (FCF) yield of approximately 13.99%. Compared to its 3-year average FCF yield of -0.52%, the current FCF yield is approximately -2777.25% lower. Relative to its 5-year average FCF yield of -0.94% , the current FCF yield is about -1592.40% lower.

3.97

P/B

Median3y

5.49

Median5y

12.33

13.99

FCF Yield

Median3y

-0.52

Median5y

-0.94

Intellectia.AI: Your Edge in Stock Trading

Join 300K+ users and access AI-powered stock picks that spot trends in minutes!

Intellectia.AI: Your Edge in Stock Trading

Join 300K+ users and access AI-powered stock picks that spot trends in minutes!

Competitors Valuation Multiple

The average P/S ratio for SKIN's competitors is 4.69, providing a benchmark for relative valuation. Beauty Health Co Corp (SKIN) exhibits a P/S ratio of 0.95, which is -79.78% above the industry average. Given its robust revenue growth of -13.70%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Profound Medical Corp

Shoulder Innovations Inc

Loss

41.04%

265.80M

Intellectia.AI: Fast-Track Your Stock Wins

Loved by 300K+ users. Get precise AI signals to ride market trends in minutes!

Intellectia.AI: Fast-Track Your Stock Wins

Loved by 300K+ users. Get precise AI signals to ride market trends in minutes!

Performance Decomposition

Market capitalization of SKIN increased by 32.96% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 0.22 to 25.21.

The secondary factor is the Revenue Growth, contributed -13.70%to the performance.

Overall, the performance of SKIN in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-13.70%

90.59M → 78.19M

Revenue Growth

11359.09%

0.22 → 25.21

Margin Expansion

-11312.43%

0.10 → -10.74

P/E Change

32.96%